Burmeister L A
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania 15261, USA.
Thyroid. 1995 Dec;5(6):435-41. doi: 10.1089/thy.1995.5.435.
To assess the efficacy of reverse T3 in differentiating between the hypothyroid and euthyroid state in the setting of illness, all reverse T3 determinations obtained over a 4-year period in a University teaching hospital were analyzed in the context of concurrent thyroid function tests, bilirubin, albumin, creatinine, subsequent treatment, and follow-up. Based on T4 (or free T4 index) and TSH, the thyroidal state of the patient and the appropriateness of the reverse T3 determination were assigned. A total of 262 reverse T3 determinations were made in 246 patients. There is an inverse linear relationship between the log TSH and the reverse T3. Patients with hypothyroidism plus illness may have a normal reverse T3 and patients with euthyroidism may have a low reverse T3. Reverse T3 is linearly related to bilirubin up to a bilirubin of approximately 171 microM (10 mg/dL). Sixty percent of the reverse T3 determinations were obtained for seemingly inappropriate indications. In association with a low free T4 index/T4, an unmeasurable reverse T3 did not lead to institution of thyroid hormone treatment in over 52% of cases. Although reverse T3 may be elevated in the setting of nonthyroidal illness, it is not reliable in distinguishing between the hypothyroid sick patient and the euthyroid sick patient. This is probably because of drug and disease effects on thyroid hormone metabolism as well as the presence of sufficient T4 substrate for conversion to reverse T3 in many hypothyroid sick patients.
为评估反三碘甲状腺原氨酸(reverse T3)在疾病状态下鉴别甲状腺功能减退和甲状腺功能正常的有效性,我们对一所大学教学医院4年期间进行的所有反三碘甲状腺原氨酸测定结果进行了分析,并结合同期的甲状腺功能检查、胆红素、白蛋白、肌酐、后续治疗及随访情况。根据血清总甲状腺素(T4)(或游离甲状腺素指数)和促甲状腺激素(TSH),确定患者的甲状腺状态以及反三碘甲状腺原氨酸测定的适宜性。共对246例患者进行了262次反三碘甲状腺原氨酸测定。log TSH与反三碘甲状腺原氨酸之间存在负线性关系。甲状腺功能减退合并疾病的患者反三碘甲状腺原氨酸可能正常,而甲状腺功能正常的患者反三碘甲状腺原氨酸可能降低。反三碘甲状腺原氨酸与胆红素呈线性相关,胆红素水平约达171微摩尔/升(10毫克/分升)时仍保持这种关系。60%的反三碘甲状腺原氨酸测定是在看似不恰当的指征下进行的。在游离甲状腺素指数/T4较低的情况下,超过52%的病例中,反三碘甲状腺原氨酸无法测得并未导致甲状腺激素治疗的开始。尽管在非甲状腺疾病状态下反三碘甲状腺原氨酸可能升高,但在区分甲状腺功能减退的患病患者和甲状腺功能正常的患病患者方面并不可靠。这可能是由于药物和疾病对甲状腺激素代谢的影响,以及许多甲状腺功能减退的患病患者中有足够的T4底物可转化为反三碘甲状腺原氨酸。